{"id":"https://openalex.org/W4386765415","doi":"https://doi.org/10.1021/acsmedchemlett.3c00390","title":"Tryptamines and Mental Health: Activating the 5\u2011HT Receptor for Therapeutic Potential","display_name":"Tryptamines and Mental Health: Activating the 5\u2011HT Receptor for Therapeutic Potential","alternate_titles":[],"publication_year":2023,"publication_date":"2023-09-15","ids":{"openalex":"https://openalex.org/W4386765415","doi":"https://doi.org/10.1021/acsmedchemlett.3c00390","pmid":"https://pubmed.ncbi.nlm.nih.gov/37849550","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10577885"},"language":"en","primary_location":{"id":"doi:10.1021/acsmedchemlett.3c00390","doi":"https://doi.org/10.1021/acsmedchemlett.3c00390","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.3c00390","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00390","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4386765415"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00390","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090796568","display_name":"Robert B. Kargbo","orcid":"https://orcid.org/0000-0002-5539-6343","observed_orcids":["https://orcid.org/0000-0002-5539-6343"]},"institutions":[{"id":"https://openalex.org/I4210116162","display_name":"Usona Institute","ror":"https://ror.org/02ebkdp37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210116162"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert B. Kargbo","raw_affiliation_strings":["Usona Institute, Fitchburg, Wisconsin, United\nStates, 53711-5300","Usona Institute, Fitchburg, Wisconsin 53711-5300, United States"],"raw_orcid":"https://orcid.org/0000-0002-5539-6343","affiliations":[{"raw_affiliation_string":"Usona Institute, Fitchburg, Wisconsin, United\nStates, 53711-5300","institution_ids":["https://openalex.org/I4210116162"]},{"raw_affiliation_string":"Usona Institute, Fitchburg, Wisconsin 53711-5300, United States","institution_ids":["https://openalex.org/I4210116162"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090796568"],"corresponding_institution_ids":["https://openalex.org/I4210116162"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"10","first_page":"1331","last_page":"1333"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tryptamine","display_name":"tryptamine","score":1.0},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/psilocybin","display_name":"psilocybin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.7480000257492065},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9620000123977661},{"id":"https://openalex.org/keywords/posttraumatic-stress-disorder","display_name":"post-traumatic stress disorder","score":1.0},{"id":"https://openalex.org/keywords/breakthrough-therapy-designation","display_name":"breakthrough therapy designation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/experiential-avoidance","display_name":"experiential avoidance","score":0.9350000023841858},{"id":"https://openalex.org/keywords/psychedelic-therapy","display_name":"psychedelic therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/mental-health","display_name":"mental health","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2909645108","wikidata":"https://www.wikidata.org/wiki/Q10705510","display_name":"Tryptamines","level":3,"score":0.9815921187400818},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5627371668815613},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4847218990325928},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3722326159477234},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34552139043807983},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33587586879730225},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3345983624458313},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.25113531947135925},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2121470868587494},{"id":"https://openalex.org/C2777135210","wikidata":"https://www.wikidata.org/wiki/Q409439","display_name":"Tryptamine","level":2,"score":0.15610376000404358},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12179160118103027}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1021/acsmedchemlett.3c00390","doi":"https://doi.org/10.1021/acsmedchemlett.3c00390","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.3c00390","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00390","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10577885","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10577885","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10577885/pdf/ml3c00390.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"},{"id":"pmid:37849550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37849550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1021/acsmedchemlett.3c00390","doi":"https://doi.org/10.1021/acsmedchemlett.3c00390","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.3c00390","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00390","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386765415.pdf","grobid_xml":"https://content.openalex.org/works/W4386765415.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W4320491739","https://openalex.org/W4360938230","https://openalex.org/W4382133350","https://openalex.org/W4382517075","https://openalex.org/W4383187032","https://openalex.org/W4386305655"],"related_works":["https://openalex.org/W7126327644","https://openalex.org/W6949927717","https://openalex.org/W4206547411","https://openalex.org/W4377081798","https://openalex.org/W7172025972","https://openalex.org/W4378549583","https://openalex.org/W4393098943","https://openalex.org/W4413284846","https://openalex.org/W4404228145","https://openalex.org/W4399371087"],"abstract_inverted_index":{"Tryptamines,":[0],"a":[1,75],"class":[2],"of":[3,51],"3-aminoethyl-indoles":[4],"that":[5],"activate":[6],"the":[7,48],"serotonin":[8],"receptor,":[9],"show":[10],"potential":[11],"for":[12,28,53,78],"novel":[13],"mental":[14,55,81],"health":[15,56,82],"treatments.":[16],"The":[17],"FDA":[18],"has":[19],"granted":[20],"\"breakthrough":[21],"therapy":[22],"designation\"":[23],"to":[24],"psilocybin":[25,52],"and":[26,34],"MDMA":[27],"treatment-resistant":[29],"depression,":[30],"major":[31],"depressive":[32],"disorder,":[33,37],"post-traumatic":[35],"stress":[36],"sparking":[38],"global":[39],"research":[40],"efforts.":[41],"Various":[42],"clinical":[43],"trials":[44],"are":[45],"currently":[46],"investigating":[47],"therapeutic":[49],"value":[50],"several":[54],"disorders.":[57],"Results":[58],"thus":[59],"far":[60],"indicate":[61],"significant":[62],"improvements":[63],"in":[64,69,80],"patient-reported":[65],"outcomes":[66],"via":[67],"reductions":[68],"experiential":[70],"avoidance.":[71],"These":[72],"advancements":[73],"highlight":[74],"promising":[76],"future":[77],"tryptamines":[79],"therapy.":[83]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4386765415","counts_by_year":[{"year":2025,"cited_by_count":12}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-09-16T00:00:00"}
